CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Operating Activities:
Net loss	$ (80,607)	$ (37,744)
Adjustments to reconcile net loss to net cash used in operating activities:
Non-cash lease expense	824	1,104
Depreciation and amortization	746	895
Stock-based compensation	8,357	437
Provision for uncollectible accounts	12,675	436
Unrealized exchange gain	(180)	(113)
Provision for inventory	1,399
Change in fair value of warrant liabilities	(8,364)	820
Change in fair value of derivative liabilities	1,730	19
Change in fair value of debt	3,751
Change in fair value of Revenue Interest Financing and PIPE Conversion Option	2,192
Change in fair value of earn-out liabilities	(29,050)
Interest paid on debt recorded at fair value	(1,092)
Non-cash interest expense	2,083	953
Non-cash termination of convertible note side letters	16,098
Loss on extinguishment of debt	3,929
Non-cash issuance of common stock for commitment shares	123
Debt issuance costs associated with debt recorded at fair value	1,210
Changes in operating assets and liabilities:
Accounts receivable	(1,318)	(22,817)
Inventory	(3,705)	(1,150)
Prepaid expenses, other current and long-term assets	285	(577)
Lease liabilities	(789)	(733)
Accounts payable	4,664	3,324
Accrued expenses and other current liabilities	1,057	8,165
Net cash used in operating activities	(63,982)	(46,981)
Investing Activities:
Purchases of property and equipment	(1,606)	(1,550)
Net cash used in investing activities	(1,606)	(1,550)
Financing Activities:
Proceeds from issuance of convertible notes - net	28,700	1,103
Proceeds from term loan - net	59,780	29,850
Payment of debt issuance costs	(3,450)	(262)
Proceeds from Business Combination, net of transaction costs	61,652
Proceeds from revenue interest financing	40,000
Repayment of promissory note assumed in Business Combination	(2,500)
Proceeds from option and warrant exercises	213	132
Repayment of convertible notes	(10,750)
Payment of deferred financing costs		(286)
Net cash provided by financing activities	95,986	30,537
Net increase (decrease) in cash and cash equivalents and restricted cash	30,398	(17,994)
Cash and cash equivalents and restricted cash at beginning of period	8,023	26,017
Cash and cash equivalents and restricted cash at end of period	38,421	8,023
Supplemental disclosure of cash flow information
Cash paid for interest	8,035	3,476
Supplemental cash flow information on non-cash investing and financing activities
Purchase of property and equipment included in accounts payable	134	13
Issuance of warrants in connection with financing		834
Deferred financing costs in accounts payable and accrued expenses	580	$ 1,919
Recognition of assumed warrant liability	13,762
Recognition of earn-out liabilities	53,040
Issuance of common stock upon conversion of convertible notes	25,569
Change in fair value of Revenue Interest Financing through OCI	(700)
2021 Term Loan
Financing Activities:
Repayment of Term Loan	(57,659)
Fortress Term Loan
Financing Activities:
Repayment of Term Loan	$ (20,000)